Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TNF Pharmaceuticals (TNFA)
NASDAQ:TNFA
Holding TNFA?
Track your performance easily
TNFA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.16 - $18.78
Previous Close$1.25
Volume29.33K
Average Volume (3M)40.04K
Market Cap
$2.96M
Enterprise Value-$5.50M
Total Cash (Recent Filing)$13.07M
Total Debt (Recent Filing)$25.80K
Price to Earnings (P/E)―
Beta1.05
Next Earnings
May 20, 2019EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.69
Shares Outstanding2,370,423
10 Day Avg. Volume28,945
30 Day Avg. Volume40,036
Standard Deviation0.33
R-Squared0.12
Alpha-0.07
Financial Highlights & Ratios
Price to Book (P/B)-62.50
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TNFA FAQ
What was TNF Pharmaceuticals’s price range in the past 12 months?
TNF Pharmaceuticals lowest stock price was $1.16 and its highest was $18.78 in the past 12 months.
What is TNF Pharmaceuticals’s market cap?
Currently, no data Available
When is TNF Pharmaceuticals’s upcoming earnings report date?
TNF Pharmaceuticals’s upcoming earnings report date is May 20, 2019 which is 2004 days ago.
How were TNF Pharmaceuticals’s earnings last quarter?
TNF Pharmaceuticals released its earnings results on Apr 01, 2019. The company reported -$3.526 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.526.
Is TNF Pharmaceuticals overvalued?
According to Wall Street analysts TNF Pharmaceuticals’s price is currently Overvalued.
Does TNF Pharmaceuticals pay dividends?
TNF Pharmaceuticals does not currently pay dividends.
What is TNF Pharmaceuticals’s EPS estimate?
TNF Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TNF Pharmaceuticals have?
TNF Pharmaceuticals has 2,370,423 shares outstanding.
What happened to TNF Pharmaceuticals’s price movement after its last earnings report?
TNF Pharmaceuticals reported an EPS of -$3.526 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of TNF Pharmaceuticals?
Currently, no hedge funds are holding shares in TNFA
---
TNF Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-91.13%
12-Months-Change
Fundamentals
Return on Equity
-297.63%
Trailing 12-Months
Asset Growth
4.49%
Trailing 12-Months
Company Description
TNF Pharmaceuticals
Akers Biosciences, Inc. develops health information technologies. It engages in the developing, manufacturing, and supplying screening and testing products to deliver healthcare information to consumers and healthcare providers. Its products include clinical diagnostics, safety diagnostics, wellness products, and tests in development. The company was founded by Raymond Francis Akers, Jr. and Raymond F. Akers, Sr. on March 8, 1989 and is headquartered in West Deptford, NJ.
---
Technical Analysis
---